Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 21, 2026, 8:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–3 of 3 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Central Line Associated Blood Stream Infections (CLABSI) Clear all

Recruiting Not applicable Interventional

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

NCT07108660

View directory record Official record

Conditions: Central Line Associated Blood Stream Infections (CLABSI)
Interventions: Infection Preventionist Led Best Practices Reminders; Behavioral
Lead sponsor: Swedish Medical Center; Other
Eligibility: 18 Years and older

Enrollment: 17,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 19
States / cities: Anchorage, Alaska • Apple Valley, California • Burbank, California + 15 more

Source: ClinicalTrials.gov public record

Updated Aug 14, 2025 · Synced May 21, 2026, 8:48 PM EDT

Completed Not applicable Interventional Results available

Passive Disinfection Cap Compliance Study

NCT03391960

View directory record Official record

Conditions: Infection, Hospital
Interventions: Passive disinfection device; Device
Lead sponsor: Solventum US LLC; Industry
Eligibility: 18 Years and older

Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Maplewood, Minnesota

Source: ClinicalTrials.gov public record

Updated Oct 1, 2024 · Synced May 21, 2026, 8:48 PM EDT

Recruiting Phase 3 Interventional

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

NCT06822426

View directory record Official record

Conditions: Central Line Associated Blood Stream Infections (CLABSI)
Interventions: (taurolidine and heparin) catheter lock solution, Heparin; Drug
Lead sponsor: CorMedix; Industry
Eligibility: 18 Years and older

Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 17
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Doral, Florida + 13 more

Source: ClinicalTrials.gov public record

Updated May 19, 2026 · Synced May 21, 2026, 8:48 PM EDT